MX369174B - Proceso para la preparación de un compuesto. - Google Patents
Proceso para la preparación de un compuesto.Info
- Publication number
- MX369174B MX369174B MX2016002198A MX2016002198A MX369174B MX 369174 B MX369174 B MX 369174B MX 2016002198 A MX2016002198 A MX 2016002198A MX 2016002198 A MX2016002198 A MX 2016002198A MX 369174 B MX369174 B MX 369174B
- Authority
- MX
- Mexico
- Prior art keywords
- preparing
- compound
- preparation
- compounds
- useful
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 abstract 1
- 102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención proporciona procesos de preparación de los mismos útiles en la preparación de compuestos que se pueden utilizar como inhibidores de CHK1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361868933P | 2013-08-22 | 2013-08-22 | |
PCT/US2014/052146 WO2015027092A1 (en) | 2013-08-22 | 2014-08-21 | Process for preparing a compound |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016002198A MX2016002198A (es) | 2016-09-08 |
MX369174B true MX369174B (es) | 2019-10-30 |
Family
ID=52484170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016002198A MX369174B (es) | 2013-08-22 | 2014-08-21 | Proceso para la preparación de un compuesto. |
Country Status (11)
Country | Link |
---|---|
US (1) | US10329288B2 (es) |
EP (1) | EP3036227B1 (es) |
JP (1) | JP6463758B2 (es) |
KR (1) | KR102325163B1 (es) |
CN (1) | CN105705499B (es) |
AR (1) | AR100020A1 (es) |
CA (1) | CA2921956C (es) |
HK (1) | HK1222392A1 (es) |
MX (1) | MX369174B (es) |
RU (1) | RU2672725C2 (es) |
WO (1) | WO2015027092A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA41599A (fr) * | 2015-02-26 | 2018-01-02 | Array Biopharma Inc | Formes cristallines d'un composé pyrrolopyridine |
CN109796349A (zh) * | 2019-03-01 | 2019-05-24 | 西南石油大学 | 一种还原芳香硝基化合物制备芳胺类化合物的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096924A (en) * | 1995-05-19 | 2000-08-01 | Novartis Ag | Process for the catalytic hydrogeneration of aromatic nitro compounds |
MXPA03000068A (es) * | 2000-06-26 | 2003-09-25 | Pfizer Prod Inc | Compuestos de pirrolo (2,3-d)pirimidina como agentes inmunosupresores. |
WO2003028724A1 (en) | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
GB0330043D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them |
SE0401001D0 (sv) * | 2004-03-31 | 2004-03-31 | Astrazeneca Ab | Chemical process |
AR054416A1 (es) * | 2004-12-22 | 2007-06-27 | Incyte Corp | Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas. |
JP2008531568A (ja) * | 2005-02-23 | 2008-08-14 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ヒドロキシアルキルで置換されたイミダゾナフチリジン |
JP5071374B2 (ja) * | 2005-07-14 | 2012-11-14 | アステラス製薬株式会社 | ヘテロ環ヤヌスキナーゼ3阻害剤 |
EP2242755B1 (en) * | 2008-01-08 | 2012-09-12 | Array Biopharma, Inc. | Pyrrolopyridines as kinase inhibitors |
CN101965347B (zh) | 2008-01-09 | 2013-01-02 | 阵列生物制药公司 | 作为激酶抑制剂的吡唑并吡啶 |
AR071717A1 (es) * | 2008-05-13 | 2010-07-07 | Array Biopharma Inc | Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer. |
HUE026671T2 (en) | 2011-08-18 | 2016-07-28 | Nippon Shinyaku Co Ltd | Heterocyclic derivatives as microsomal prostaglandin E synthetase inhibitors (mPGEs) |
GB201201566D0 (en) | 2012-01-30 | 2012-03-14 | Vernalis R&D Ltd | New chemical compounds |
-
2014
- 2014-08-21 CN CN201480054349.1A patent/CN105705499B/zh active Active
- 2014-08-21 CA CA2921956A patent/CA2921956C/en active Active
- 2014-08-21 RU RU2016110081A patent/RU2672725C2/ru active
- 2014-08-21 WO PCT/US2014/052146 patent/WO2015027092A1/en active Application Filing
- 2014-08-21 EP EP14838336.7A patent/EP3036227B1/en active Active
- 2014-08-21 MX MX2016002198A patent/MX369174B/es active IP Right Grant
- 2014-08-21 US US14/913,635 patent/US10329288B2/en active Active
- 2014-08-21 JP JP2016536458A patent/JP6463758B2/ja not_active Expired - Fee Related
- 2014-08-21 KR KR1020167007101A patent/KR102325163B1/ko active IP Right Grant
- 2014-08-22 AR ARP140103155A patent/AR100020A1/es unknown
-
2016
- 2016-09-06 HK HK16110566.5A patent/HK1222392A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2921956A1 (en) | 2015-02-26 |
KR20160043116A (ko) | 2016-04-20 |
US10329288B2 (en) | 2019-06-25 |
WO2015027092A1 (en) | 2015-02-26 |
RU2672725C2 (ru) | 2018-11-19 |
RU2016110081A (ru) | 2017-09-27 |
MX2016002198A (es) | 2016-09-08 |
CA2921956C (en) | 2021-10-19 |
EP3036227B1 (en) | 2020-01-08 |
CN105705499B (zh) | 2018-10-12 |
EP3036227A4 (en) | 2017-01-04 |
CN105705499A (zh) | 2016-06-22 |
EP3036227A1 (en) | 2016-06-29 |
JP2016528296A (ja) | 2016-09-15 |
KR102325163B1 (ko) | 2021-11-11 |
HK1222392A1 (zh) | 2017-06-30 |
JP6463758B2 (ja) | 2019-02-06 |
US20160200723A1 (en) | 2016-07-14 |
AR100020A1 (es) | 2016-09-07 |
RU2016110081A3 (es) | 2018-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX370649B (es) | Proceso para la preparacion de teneligliptina. | |
HK1217041A1 (zh) | 測定成膜胺的方法 | |
HK1224281A1 (zh) | 磷脂酰肌醇 -激酶抑制劑的製備方法 | |
MX337094B (es) | Proceso e intermediarios para preparar inhibidores de integrasa. | |
IN2013MU00646A (es) | ||
HUE058802T2 (hu) | RIPK1 inhibitorokként alkalmas vegyületek | |
IN2014DN08777A (es) | ||
PH12016501183A1 (en) | Novel compound for treatment of severe hypoglycemia | |
IN2013MU01113A (es) | ||
PH12016501184A1 (en) | Novel compound for treatment of severe hypoglycemia | |
PH12016501182A1 (en) | Novel compound for treatment of severe hypoglycemia | |
MX369174B (es) | Proceso para la preparación de un compuesto. | |
IN2013MU04056A (es) | ||
PT2799426T (pt) | Novo processo para a síntese de aminaftona | |
IN2013MU03768A (es) | ||
IN2013MU01501A (es) | ||
IN2013CH05395A (es) | ||
MY168958A (en) | Intermediates and processes for preparing compounds | |
IN2013CH05884A (es) | ||
IN2013CH05769A (es) | ||
IL240819A0 (en) | An improved process for the production of moxonidine | |
IN2013MU03841A (es) | ||
EP3077376A4 (en) | Process for making reverse transcriptase inhibitors | |
IN2013MU03466A (es) | ||
IL231694A0 (en) | A process for producing a nitrile compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |